[go: up one dir, main page]

AU1932395A - Method for treating and inhibiting gastric and duodenal ulcers - Google Patents

Method for treating and inhibiting gastric and duodenal ulcers

Info

Publication number
AU1932395A
AU1932395A AU19323/95A AU1932395A AU1932395A AU 1932395 A AU1932395 A AU 1932395A AU 19323/95 A AU19323/95 A AU 19323/95A AU 1932395 A AU1932395 A AU 1932395A AU 1932395 A AU1932395 A AU 1932395A
Authority
AU
Australia
Prior art keywords
treating
duodenal ulcers
inhibiting gastric
gastric
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU19323/95A
Other versions
AU709149B2 (en
Inventor
Dennis H Langer
Edward J Mcguire
Stephen Roth
Paul M Simon
David A Zopf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neose Technologies Inc
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Publication of AU1932395A publication Critical patent/AU1932395A/en
Assigned to NEOSE TECHNOLOGIES, INC. reassignment NEOSE TECHNOLOGIES, INC. Amend patent request/document other than specification (104) Assignors: NEOSE PHARMACEUTICALS, INC.
Application granted granted Critical
Publication of AU709149B2 publication Critical patent/AU709149B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AU19323/95A 1994-03-02 1995-03-02 Method for treating and inhibiting gastric and duodenal ulcers Ceased AU709149B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20451594A 1994-03-02 1994-03-02
US204515 1994-03-02
PCT/US1995/002388 WO1995023605A1 (en) 1994-03-02 1995-03-02 Method for treating and inhibiting gastric and duodenal ulcers

Publications (2)

Publication Number Publication Date
AU1932395A true AU1932395A (en) 1995-09-18
AU709149B2 AU709149B2 (en) 1999-08-19

Family

ID=22758224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19323/95A Ceased AU709149B2 (en) 1994-03-02 1995-03-02 Method for treating and inhibiting gastric and duodenal ulcers

Country Status (5)

Country Link
EP (1) EP0749314A4 (en)
JP (1) JP3179108B2 (en)
AU (1) AU709149B2 (en)
CA (1) CA2183329A1 (en)
WO (1) WO1995023605A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
CA2253913A1 (en) * 1996-05-03 1997-11-13 Herbert Swarz Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
US8003782B1 (en) 1999-02-01 2011-08-23 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
SE9901007D0 (en) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
FI20021989A0 (en) * 2002-11-06 2002-11-06 Halina Miller-Podraza High affinity Helicobacter pylori receptors and their use
NL2007931C2 (en) * 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
US12138308B2 (en) 2018-09-20 2024-11-12 Enbiar Inc. Polymer composite for helicobacter pylori recognition and composition for photodynamic therapy comprising same
WO2020060260A1 (en) * 2018-09-20 2020-03-26 가톨릭대학교 산학협력단 Polymer composite for helicobacter pylori recognition and composition for photodynamic therapy comprising same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464687B (en) * 1987-11-10 1991-06-03 Biocarb Ab PROCEDURES FOR PREPARING A GEL PRODUCT
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JPH0436294A (en) * 1990-06-01 1992-02-06 Snow Brand Milk Prod Co Ltd Novel gangliside originated from milk and its preparation
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
EP0630251A1 (en) * 1992-03-19 1994-12-28 University Of British Columbia Method and composition for suppression of side effects of anti-inflammatory drugs
AU4055993A (en) * 1992-05-15 1993-12-13 University Of British Columbia, The N-acetyl glucosamine as gastroprotective agent
WO1994003184A1 (en) * 1992-07-31 1994-02-17 Neose Pharmaceuticals, Inc. Compositions for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
JP3179108B2 (en) 2001-06-25
WO1995023605A1 (en) 1995-09-08
CA2183329A1 (en) 1995-09-08
EP0749314A4 (en) 2002-09-18
EP0749314A1 (en) 1996-12-27
JPH09509931A (en) 1997-10-07
AU709149B2 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
SG55323A1 (en) Substrate treating system and substrate treating method
SG65007A1 (en) Substrate treatment system substrate transfer system and substrate transfer method
AU1749592A (en) Method and device for treating myopia
AU7379896A (en) Method and apparatus for improving the function of sensory cells
AU4170797A (en) Method and apparatus for crosstalk cancellation
AU5387796A (en) Method and compositions for treating impotence
AU3553795A (en) Apparatus and method for clampling a substrate
SG73986A1 (en) Method for treating bioorganic and wastewater sludges
AU2046397A (en) Method and device for treating a substrate
AU8095491A (en) Method and device for treating epilepsy
AU6291894A (en) Method and apparatus for purifying water
AU693186B2 (en) Wastewater treatment method and apparatus
AU4993893A (en) Compositions for treating and inhibiting gastric and duodenal ulcers
AU1912992A (en) Method for treating hypothermia
AU3040795A (en) Method and composition for treating intestinal wounds or ulcers
AU5544996A (en) Apparatus and method for line placement
AU1932395A (en) Method for treating and inhibiting gastric and duodenal ulcers
AU4853293A (en) Method and apparatus for treating fuel
AU3838793A (en) Method for preventing and treating atherosclerosis
AU5356494A (en) Product and method for treating asbestos
AU7726396A (en) Method for treating anxiety
AU4672597A (en) Method for treating urinary reflux
EP0714059A3 (en) Method and apparatus for controlling memory operationsM
AU7674796A (en) Method for treating anxiety
AU5100996A (en) Method and device for treating foodstuffs

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired